AddLife AB (publ)
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ALIF-B.ST research report →
Companywww.add.life
AddLife AB (publ), together with its subsidiaries, provides equipment, medical devices, and reagents primarily to healthcare system, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates in two segments, Labtech and Medtech. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory equipment for haematology, pathology, point-of-care diagnostics, cell biology, genetics, microbiology, virology, molecular biology, clinical chemistry, immunology, consumables, and analytical instruments segments.
- CEO
- Fredrik Dalborg
- IPO
- 2016
- Employees
- 2,251
- HQ
- Stockholm, SE
Price Chart
Valuation
- Market Cap
- $17.55B
- P/E
- 32.10
- P/S
- 1.69
- P/B
- 3.22
- EV/EBITDA
- 15.48
- Div Yield
- 1.00%
Profitability
- Gross Margin
- 38.29%
- Op Margin
- 7.45%
- Net Margin
- 5.47%
- ROE
- 10.48%
- ROIC
- 5.16%
Growth & Income
- Revenue
- $10.44B · 1.52%
- Net Income
- $560.00M · 122.22%
- EPS
- $4.60 · 122.22%
- Op Income
- $780.00M
- FCF YoY
- 42.61%
Performance & Tape
- 52W High
- $208.40
- 52W Low
- $130.20
- 50D MA
- $147.11
- 200D MA
- $163.93
- Beta
- 1.57
- Avg Volume
- 147.05K
Get TickerSpark's AI analysis on ALIF-B.ST
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our ALIF-B.ST Coverage
We haven't published any research on ALIF-B.ST yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate ALIF-B.ST Report →